Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease. 2013

Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul, Korea.

Interleukin (IL)-33 is an important mediator of innate immunity. Behcet's disease (BD) is an autoinflammatory disorder characterized by hyperactivity of the innate immune response. We measured serum levels of IL-33 and its receptor soluble ST2 (sST2) in patients with BD to investigate their association with disease activity. Serum levels of both IL-33 and sST2 were higher in patients with BD compared with those in normal controls (IL-33: 594.48±175.04 pg/mL in BD and 224.23±56.64 pg/mL in normal controls [P=0.048], sST2: 99.01±15.92 pg/mL in BD and 23.56±3.25 pg/mL in normal controls [P<0.001]). IL-33 and sST2 expression in skin tissue, as shown by immunohistochemistry, was higher in patients with BD compared with that in the normal controls. Serum sST2 level correlated significantly with the BD currently active form (BDCAF), Iranian BD dynamic activity measure (IBDDAM), erythrocyte sedimentation rate and C-reactive protein. Multiple linear regression showed that serum sST2 was an independent factor associated with IBBDAM (regression coefficient, 0.374; P=0.004), and BDCAF (regression coefficient, 0.236; P=0.047). These results demonstrate that IL-33 and sST2 are highly expressed in patients with BD and that serum sST2 is an independent factor associated with IBDDAM and BDCAF, suggesting a potential role for sST2 as a surrogate marker of disease activity in patients with BD.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D001799 Blood Sedimentation Measurement of rate of settling of ERYTHROCYTES in blood. Erythrocyte Sedimentation,Erythrocyte Sedimentation Rate,Erythrocyte Sedimentation Rates,Rate, Erythrocyte Sedimentation,Rates, Erythrocyte Sedimentation,Sedimentation Rate, Erythrocyte,Sedimentation Rates, Erythrocyte,Sedimentation, Blood,Sedimentation, Erythrocyte
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067596 Interleukin-33 A member of the INTERLEUKIN-1 protein family involved in the maturation of TH2 CELLS and the activation of MAST CELLS; BASOPHILS; EOSINOPHILS and NK CELLS. It is also produced by ENDOTHELIAL CELLS; EPITHELIAL CELLS and FIBROBLASTS; where it can function as an alarmin to modulate immune and inflammatory responses to tissue damage. IL-33,IL33,Interleukin 33

Related Publications

Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
June 2012, Journal of clinical immunology,
Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
January 2021, Frontiers in immunology,
Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
September 2012, Journal of reproductive immunology,
Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
March 2010, Rheumatology (Oxford, England),
Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
September 2013, International journal of cardiology,
Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
January 2013, Clinical and experimental rheumatology,
Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
June 2015, The Egyptian journal of immunology,
Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
January 2024, The Journal of asthma : official journal of the Association for the Care of Asthma,
Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
October 2010, The Journal of surgical research,
Dae-Jun Kim, and Seung-Ye Baek, and Mi-Kyung Park, and Kyung-Su Park, and Jae Ho Lee, and Sung-Hwan Park, and Ho-Youn Kim, and Seung-Ki Kwok
June 2017, The Journal of rheumatology,
Copied contents to your clipboard!